Abstract
Angiotensin converting enzyme (EC 3.4.15.1:ACE) plays a crucial role in the renin-angiotensin cascade by its catalytic action of the conversion of angiotensin(ANG) I to ANG II, although the enzyme also degrades bradykinin and some other peptides. ACE in the lung and plasma can influence the plasma ANG II level, however, the role of ACE in other organs such as kidney, brain, vascular wall, heart etc. have been considered in view of the tissue(or local) renin-angiotensin system that appreciates the significance of production of ANG II at the site of its actions1,2.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
V.J. Dzau, Significance of the vascular renin-angiotensin pathway. Hypertension 8: 553(1986).
T. Unger, D. Ganten, and R.E. Lang, Tissue converting enzyme and cardiovascular actions of converting enzyme inhibitors. JCardiovas.Pharmacol. 8(suppl 10):s75(1986).
P.E. Ward, E.G. Erdos, C.D. Gedney et al.,Isolation of membrane-bound renal enzymes that metabolize kinins and angiotensins. BiochemJ. 157: 643 (1976).
P.E. Ward, and M.S. Sheridan, Converting enzyme kininase and angioten-sinase of renal and intestinal brush border. Adv Exp. Med. Biol. 156: 835 (1983).
F. Ikemoto, M. Tanaka, S. Itoh et al., Angiotensin converting enzyme(ACE) in the kidney:contribution to blood pressure regulation and possible role of brush-border ACE. JCardiovas.Pharmacol. 8(suppl 10):s69(1986).
P. Malathi, H. Preiser, P. Fairclough et al., A rapid method for the isolation of kidney brush border membranes. Biochim Biophys. Acta 554: 259 (1979).
D.W. Cushman, H.S. Cheung, E.F. Sabo, and M.A. Ondetti, Design of potent competitive inhibitor of angiotensin-converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acids. Biochemistry 16: 5484(1977).
S.Y. Chai, A.M. Allen, W.R. Adams, and F.A.O. Mendelsohn, Local actions of angiotensin II receptor binding and angiotensin converting enzyme in target tissues. JCardiovas.Pharmacol. 8(suppl 10):s35(1986).
F. Ikemoto, G. Song, M. Tominaga et al., Angiotensin converting enzyme predominates in the inner cortex and medulla of the rat kidney. Biochem. Biophys Res. Commun. 144: 915(1987).
S.K. Wilson, D.R. Lynch, and S.H. Snyder, Angiotensin-converting enzyme labelled with [3H]captopril. JClin.Invest. 80: 841(1987).
T. Kokubu, E. Ueda, M. Ono et al., Effects of Captopril(SQ14,225) on the renin-angiotensin-aldosterone system in normal rats. EurJ.Pharmacol. 62: 269(1980).
T. Forslund, I. Kouvonen, and F. Fyhrquist, Tissue distribution of converting enzyme in the rat:Effect of Captopril treatment. Acta harmacol. Toxicol. 54: 124(1984)
F. Fyhrquist, L. Hortling, and C. Gronhagen-Riska, Induction of angiotensin I-converting enzyme by Captopril in cultured human endothelial cells. JEndocrinol.Metab. 55: 783(1982).
F. Boomsam, J.H.B. DeBruyn, F.H.M. Derkx, M.A.D.H. Schalekamp. Opposite effects of Captopril on angiotensin I-converting enzyme ‘activity’ and ‘concentration’; relation between enzyme inhibition and long-term blood pressure response. Clinical cience 60: 491(1980).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Plenum Press, New York
About this chapter
Cite this chapter
Ikemoto, F., Song, GB., Tominaga, M., Kanayama, Y., Yamamoto, K. (1989). Regional Distribution of Angiotensin Converting Enzyme in the Rat Kidney. In: Abe, K., Moriya, H., Fujii, S. (eds) Kinins V. Advances in Experimental Medicine and Biology, vol 247 A. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-9543-4_23
Download citation
DOI: https://doi.org/10.1007/978-1-4615-9543-4_23
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4615-9545-8
Online ISBN: 978-1-4615-9543-4
eBook Packages: Springer Book Archive